Associated Papers
Assessment of pharmacogenomic SLCO1B1 assay for prediction of neuromuscular pain in type 2 diabetes mellitus and cardiovascular patients: preliminary results.
Licito A et al.
European Review for Medical and Pharmacological Sciences, 2020
Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects.
Zhou Y et al.
Clinical Pharmacology and Therapeutics, 2017
Effects of functional CYP2C8,CYP2C9,CYP3A5,and ABCB1 genetic variants on the pharmacokinetics of insulin sensitizer pioglitazone in Chinese Han individuals.
Yin SJ et al.
Pharmacogenetics and Genomics, 2017
Pharmacogenetics in Jewish populations.
Yang Y et al.
Drug Metabolism and Drug Interactions, 2014
Influence of genetic variations on levels of inflammatory markers of healthy subjects at baseline and one week after clopidogrel therapy; results of a preliminary study.
Shahabi P et al.
International Journal of Molecular Sciences, 2013
Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes.
Martis S et al.
The Pharmacogenomics Journal, 2013
Prevalence of CYP2C8 polymorphisms in a North Indian population.
Minhas S et al.
Genetics and Molecular Research : Gmr, 2013
Frequencies of Cytochrome P450 2B6 and 2C8 Allelic Variants in the Mozambican Population.
Arnaldo P et al.
The Malaysian Journal of Medical Sciences : Mjms, 2013
CYP2C19*17 gain-of-function polymorphism is associated with peptic ulcer disease.
Musumba CO et al.
Clinical Pharmacology and Therapeutics, 2013
Genetic polymorphisms of CYP2C8 in the Czech Republic.
Pechandova K et al.
Genetic Testing and Molecular Biomarkers, 2012
Association of cytochrome P450 genetic polymorphisms with neoadjuvant chemotherapy efficacy in breast cancer patients.
Seredina TA et al.
Bmc Medical Genetics, 2012
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation.
Zanger UM et al.
Analytical and Bioanalytical Chemistry, 2008
Do single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility and treatment outcomes?
Singh V et al.
Cancer Investigation, 2008
Characterization of novel CYP2C8 haplotypes and their contribution to paclitaxel and repaglinide metabolism.
Rodríguez-Antona C et al.
The Pharmacogenomics Journal, 2008
Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers.
López-Rodríguez R et al.
Pharmacological Research, 2008
Predicting drug response and toxicity based on gene polymorphisms.
Robert J et al.
Critical Reviews in Oncology/hematology, 2005